NYSE: CVSCVS HEALTH Corp Stock
$83.70+0.66 (0.79%)
Updated May 6, 2021
CVS Price
$83.70
Fair Value Price
N/A
Market Cap
$109.76B
52 Week Low
$55.36
52 Week High
$83.75
P/E
14.87x
P/B
1.55x
P/S
0.36x
PEG
0.77x
Dividend Yield
2.39%
Revenue
$271.05B
Earnings
$7.40B
Gross Margin
18.3%
Operating Margin
4.71%
Profit Margin
2.7%
Debt to Equity
2.24
Operating Cash Flow
$15B
Beta
0.8
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Score
High
Medium
Low
33
Industry average
Reasons for this score
CVS ($83.70) is trading below its intrinsic value of $440.15, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
CVS is good value based on its earnings relative to its share price (14.87x), compared to the US market average 27.98x)
Valuation
CVS is good value based on its earnings relative to its share price (14.87x), compared to the US Healthcare Plans industry average (17.95x)
Valuation
CVS News
Valuation
CVS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
14.87x
Industry
17.95x
Market
27.98x
CVS is good value based on its earnings relative to its share price (14.87x), compared to the US market average 27.98x)
Valuation
CVS is good value based on its earnings relative to its share price (14.87x), compared to the US Healthcare Plans industry average (17.95x)
Valuation
CVS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.55x
Industry
3.08x
Market
0.6x
CVS is poor value based on its book value relative to its share price (1.55x), compared to the US market average (0.6x)
Valuation
CVS is good value based on its book value relative to its share price (1.55x), compared to the US Healthcare Plans industry average (3.08x)
Valuation
CVS price to earnings growth (PEG)
For valuing profitable companies with growth potential
CVS is good value based on it's Price to Earnings and rate of earnings growth, measured by PEG ratio (0.77x)
Valuation
CVS's financial health
Profit margin
Revenue
$69.1B
Net Income
$2.2B
Profit Margin
3.2%
CVS's Earnings (EBIT) of $12.77B are insufficient to safely cover interest payments on company debt ($82.32B)
Financials
CVS's profit margin has decreased (-0.1%) in the last year from (2.8%) to (2.7%)
Financials
Assets to liabilities
Assets
$229.6B
Liabilities
$158.4B
Debt to equity
1.16
CVS's short-term liabilities ($60.10B) exceed its short-term assets ($55.72B)
Financials
CVS's long-term liabilities ($98.34B) exceed its short-term assets ($55.72B)
Financials
CVS's debt has increased relative to shareholder equity (2.24), over the past 5 years ago (1.57)
Financials
CVS's debt to equity ratio (2.24) is considered high
Financials
Cash flow
Operating
$2.9B
Investing
-$1.9B
Financing
-$3.2B
CVS's operating cash flow ($15.45B) may not be sufficient to safely service the company's debt ($82.32B)
Financials
CVS HEALTH Corp Stock FAQ
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.